Drug Discovery Informatics Market Size and Share 2034
Drug Discovery Informatics Market Growth, Size, Trends Analysis - By Product Type, By Functionality, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Oct-2025 | Report ID: PHAR2532 | Pages: 1 - 263 | Formats*: |
| Category : Pharmaceutical | |||
Drug Discovery Informatics Market Introduction and Overview
According to SPER Market Research, the Global Drug Discovery Informatics Market is estimated to reach USD 11.29 billion by 2034 with a CAGR of 11.74%.
The report includes an in-depth analysis of the Global Drug Discovery Informatics Market, including market size and trends, product mix, Applications, and supplier analysis. The global drug discovery informatics market was valued at USD 3.72 billion in 2024 and is projected to experience a compound annual growth rate (CAGR) of 11.74% from 2025 to 2034. This growth can be attributed to several factors, such as advancements in high-performance computing and web services, an increased adoption of in-silico modeling tools, a growing volume of data in drug discovery, and a rising demand for innovative drug molecules.
By Product Type Insights:
The drug discovery informatics market is divided into software and services, with software leading the market in 2024. The drug discovery process is complex, involving target identification, lead optimization, and clinical data management, which requires advanced programs for handling multi-omic data and large datasets. The focus on creating patient-first therapies through precision medicine drives the need for software solutions that integrate and analyze genomic, proteomic, and clinical data. There is also a growing preference for cloud-based software among pharmaceutical and biotechnology companies because these solutions are scalable, accessible, and cost-effective.
By Functionality Insights:
Functionally, the market is divided into sequencing and target data analysis, docking, molecular modeling, and other areas, with sequencing and target data analysis holding the largest share in 2024. Next Generation Sequencing (NGS) and other advanced techniques provide deep insights into genetic data, aiding in drug targeting. Machine learning and artificial intelligence enhance these capabilities by improving data processing, which helps in analyzing biological systems and disease pathways, thereby supporting drug discovery efforts.
By Application Insights:
The market is categorized by application into drug discovery and drug development, with drug discovery being the leading segment in 2024. The rise of technology in pharmaceuticals is driven by the need for innovative drug discovery methods to address rare and chronic diseases. AI and machine learning facilitate faster target identification and lead optimization, thanks to the increasing availability of datasets.
By End User Insights:
The drug discovery informatics market is divided based on end users, including pharmaceutical and biotechnology companies, contract research organizations, and academic institutions. In 2024, pharmaceutical and biotechnology companies led the market, driven by increased R&D budgets. These companies invest significantly in research to develop new therapies and drugs. Drug discovery informatics solutions help improve efficiency, making recovery of costs easier. There is also a growing focus on precision medicine and rising demand for biosimilars and biologics.
Regional Insights:
In 2024, North America led the drug discovery informatics market, primarily due to increased investments in research and development (R&D) activities aimed at drug discovery, along with advancements in data mining and analytics technologies. These developments have played a significant role in the market's expansion by facilitating more efficient and effective analysis of large data volumes in the drug discovery process. By utilizing advanced informatics tools and techniques, researchers and pharmaceutical companies can derive valuable insights and make informed decisions, thereby accelerating drug discovery and development efforts.
Market Competitive Landscape:
Key market players are making substantial investments in research and development to broaden their offerings, which will further enhance the growth of the drug discovery informatics market. Additionally, market participants are engaging in various strategic initiatives to expand their global presence, with notable market developments including innovative product launches, international collaborations, increased investments, and mergers and acquisitions among organizations. To thrive and remain competitive in a rapidly evolving market landscape, the drug discovery informatics industry must provide cost-effective solutions.
Recent Developments:
In October 2024, Certara, a frontrunner in model-informed drug development, completed its acquisition of Chemaxon, a scientific informatics firm, to bolster drug discovery and development efforts.
In February 2024, Eurofins Discovery introduced DiscoveryAI SAFIRE, an AI-driven platform that forecasts ADMET properties utilizing proprietary datasets, thereby accelerating the drug discovery process and enhancing accuracy through sophisticated machine learning and the integration of its extensive BioPrint database.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product Type, By Functionality, By Application, By End User |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Accenture, Agilent Technologies, Albany Molecular Research, Boehringer Ingelheim International, Charles River Laboratories, Collaborative Drug Discovery, Eurofins Scientific, Illumina, Jubilant Life Sciences, Novo Informatics, Oracle Corporation. |
- Global Drug Discovery Informatics Market Size (FY 2021-FY 2034)
- Overview of Global Drug Discovery Informatics Market
- Segmentation of Global Drug Discovery Informatics Market By Product Type (Software, Services)
- Segmentation of Global Drug Discovery Informatics Market By Functionality (Sequencing and target data analysis, Docking, Molecular modelling, other functionalities)
- Segmentation of Global Drug Discovery Informatics Market By Application (Drug discovery, Drug development)
- Segmentation of Global Drug Discovery Informatics Market By End User (Pharmaceutical and biotechnology companies, Contract research organizations, Academic and research institutes, other end users)
- Statistical Snap of Global Drug Discovery Informatics Market
- Expansion Analysis of Global Drug Discovery Informatics Market
- Problems and Obstacles in Global Drug Discovery Informatics Market
- Competitive Landscape in the Global Drug Discovery Informatics Market
- Details on Current Investment in Global Drug Discovery Informatics Market
- Competitive Analysis of Global Drug Discovery Informatics Market
- Prominent Players in the Global Drug Discovery Informatics Market
- SWOT Analysis of Global Drug Discovery Informatics Market
- Global Drug Discovery Informatics Market Future Outlook and Projections (FY 2025-FY 2034)
- Recommendations from Analyst
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Global Drug Discovery Informatics Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Drug Discovery Informatics Market
7. Global Drug Discovery Informatics Market, By Product Type (USD Million) 2021-2034
- 7.1. Software
- 7.2. Services
8. Global Drug Discovery Informatics Market, By Functionality (USD Million) 2021-2034
- 8.1. Sequencing and target data analysis
- 8.2. Docking
- 8.3. Molecular modeling
- 8.4. Other functionalities
9. Global Drug Discovery Informatics Market, By Application (USD Million) 2021-2034
- 9.1. Drug discovery
- 9.2. Drug development
10. Global Drug Discovery Informatics Market, By End User (USD Million) 2021-2034
- 10.1. Pharmaceutical and biotechnology companies
- 10.2. Contract research organizations (CROs)
- 10.3. Academic and research institutes
- 10.4. Other end users
11. Global Drug Discovery Informatics Market, (USD Million) 2021-2034
- 13.1. Global Drug Discovery Informatics Market Size and Market Share
12. Global Drug Discovery Informatics Market, By Region, (USD Million) 2021-2034
- 12.1. Asia-Pacific
- 12.1.1. Australia
- 12.1.2. China
- 12.1.3. India
- 12.1.4. Japan
- 12.1.5. South Korea
- 12.1.6. Rest of Asia-Pacific
- 12.2. Europe
- 12.2.1. France
- 12.2.2. Germany
- 12.2.3. Italy
- 12.2.4. Spain
- 12.2.5. United Kingdom
- 12.2.6. Rest of Europe
- 12.3. Middle East and Africa
- 12.3.1. Kingdom of Saudi Arabia
- 12.3.2. United Arab Emirates
- 12.3.3. Qatar
- 12.3.4. South Africa
- 12.3.5. Egypt
- 12.3.6. Morocco
- 12.3.7. Nigeria
- 12.3.8. Rest of Middle-East and Africa
- 12.4. North America
- 12.4.1. Canada
- 12.4.2. Mexico
- 12.4.3. United States
- 12.5. Latin America
- 12.5.1. Argentina
- 12.5.2. Brazil
- 12.5.3. Rest of Latin America
13. Company Profile
- 13.1. Accenture
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
- 13.2. Agilent Technologies
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
- 13.3. Albany Molecular Research
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
- 13.4. Boehringer Ingelheim International
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
- 13.5. Charles River Laboratories
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
- 13.6. Collaborative Drug Discovery
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
- 13.7. Eurofins Scientific
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
- 13.8. Illumina
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
- 13.9. Jubilant Life Sciences
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
- 13.10. Novo Informatics
- 15.10.1. Company details
- 15.10.2. Financial outlook
- 15.10.3 Product summary
- 15.10.4. Recent developments
- 13.11. Oracle Corporation
- 15.11.1. Company details
- 15.11.2. Financial outlook
- 15.11.3. Product summary
- 15.11.4. Recent developments
- 15.15. Others
14.Conclusion
15.List of Abbreviations
16.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Drug Discovery Informatics Market is projected to reach USD 11.29 billion by 2034, growing at a CAGR of of 11.74% during the forecast period.
Drug Discovery Informatics Market grew in Market size from 2025. The Market is expected to reach USD 11.29 billion by 2034, at a CAGR of 11.74 billion% during the forecast period.
Drug Discovery Informatics Market CAGR of 11.74% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Drug Discovery Informatics Market size is USD 11.29 billion from 2025 to 2034.
Drug Discovery Informatics Market is covered By Product Type, By Functionality, By Application, By End User
The North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa is the highest Market share in the Drug Discovery Informatics Market.
Accenture, Agilent Technologies, Albany Molecular Research, Boehringer Ingelheim International, Charles River Laboratories, Collaborative Drug Discovery, Eurofins Scientific, Illumina, Jubilant Life Sciences, Novo Informatics, Oracle Corporation.
The report includes an in-depth analysis of the Global Drug Discovery Informatics Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
